Table 3.
Activities of besifloxacin and other antibiotics against anaerobic bacteria21
Species (no of test isolates) and test drug | MICa (μg/mL) |
||
---|---|---|---|
Range | 50% | 90% | |
Clostridium perfringens (n = 21) | |||
Besifloxacin | 0.12–0.25 | 0.25 | 0.25 |
Moxifloxacin | 0.25–0.5 | 0.5 | 0.5 |
Gatifloxacin | 0.5–1 | 1 | 1 |
Clindamycin | 0.06–4 | 2 | 4 |
Metronidazole | 1–4 | 2 | 4 |
Fusobacterium species (n = 21) | |||
Besifloxacin | 0.12–8 | 0.25 | 1 |
Moxifloxacin | 0.25 to >16 | 1 | 2 |
Gatifloxacin | 0.5 to >16 | 1 | 4 |
Clindamycin | 0.06–8 | 0.06 | 2 |
Metronidazole | ≤0.12–2 | 0.25 | 1 |
Peptostreptococcus species (n = 52) | |||
Besifloxacin | 0.06–2 | 0.25 | 0.5 |
Moxifloxacin | 0.25–4 | 0.25 | 0.5 |
Ciprofloxacin | 0.5 to >8 | 2 | 4 |
Clindamycin | 0.06 to >8 | 0.25 | >8 |
Metronidazole | ≤0.03 to >16 | 0.5 | 1 |
Propionibacterium acnes (n = 21) | |||
Besifloxacin | 0.12–0.25 | 0.25 | 0.25 |
Moxifloxacin | 0.25–0.25 | 0.25 | 0.25 |
Gatifloxacin | 0.25–0.5 | 0.25 | 0.5 |
Clindamycin | ≤0.03–2 | 0.06 | 0.12 |
Metronidazole | >16 to >16 | >16 | >16 |
Minimum inhibitory concentration.